Impact of duration of untreated psychosis on remission in first-episode schizophrenia in Thailand: a cohort study

Bibliographic Details
Main Author: Takizawa , Patcharapim
Publication Date: 2021
Other Authors: Sareedenchai , Pairoj, Wongsiri, Kanjana, Amornmahaphun, Sucheera, Kuroda, Naoaki, Hori , Ai, Ichikawa , Masao
Format: Article
Language: eng
Source: Archives of Clinical Psychiatry
Download full: https://revistas.usp.br/acp/article/view/231766
Summary: Background: To scale up the services for first-episode schizophrenia in Thailand, it is essential to understand to what extent health care-seeking is delayed, and how much the delay affects the treatment outcome.Objectives: To investigate the duration of untreated psychosis (DUP) and its impact on remission in first-episode schizophrenia across the country.Methods: 276 outpatients with a first-episode schizophrenia were followed for 6 months and assessed whether they fulfilled the criteria for remission at the follow-up. The proportion of those achieving remission was compared by the DUP. The impact of DUP on remission was estimated in multivariate analyses.Results: At the follow-up, 83% (71/86) of patients who had met the criteria for symptomatic remission at the baseline achieved enduring remission, whereas 63% (119/190) of patients who had not met the criteria for symptomatic remission at baseline met it at the follow-up. The shorter the DUP, the higher the proportion of those who achieved symptomatic or enduring remission at the follow-up. The impact of DUP on symptomatic remission appeared to be significant after controlling for other factors influencing remission.Conclusion: Since the DUP would influence remission of patients with schizophrenia, early detection and intervention services should be provided in Thailand
id USP-5_ebba4ff0f45e2bbb0e033bbc5ac55d29
oai_identifier_str oai:revistas.usp.br:article/231766
network_acronym_str USP-5
network_name_str Archives of Clinical Psychiatry
repository_id_str
spelling Impact of duration of untreated psychosis on remission in first-episode schizophrenia in Thailand: a cohort study Duration of untreated psychosisFirst-episode schizophreniaRemissionCohortThailandBackground: To scale up the services for first-episode schizophrenia in Thailand, it is essential to understand to what extent health care-seeking is delayed, and how much the delay affects the treatment outcome.Objectives: To investigate the duration of untreated psychosis (DUP) and its impact on remission in first-episode schizophrenia across the country.Methods: 276 outpatients with a first-episode schizophrenia were followed for 6 months and assessed whether they fulfilled the criteria for remission at the follow-up. The proportion of those achieving remission was compared by the DUP. The impact of DUP on remission was estimated in multivariate analyses.Results: At the follow-up, 83% (71/86) of patients who had met the criteria for symptomatic remission at the baseline achieved enduring remission, whereas 63% (119/190) of patients who had not met the criteria for symptomatic remission at baseline met it at the follow-up. The shorter the DUP, the higher the proportion of those who achieved symptomatic or enduring remission at the follow-up. The impact of DUP on symptomatic remission appeared to be significant after controlling for other factors influencing remission.Conclusion: Since the DUP would influence remission of patients with schizophrenia, early detection and intervention services should be provided in ThailandUniversidade de São Paulo. Faculdade de Medicina. Instituto de Psiquiatria2021-06-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://revistas.usp.br/acp/article/view/23176610.15761/0101-60830000000296Archives of Clinical Psychiatry; v. 48 n. 3 (2021); 141-146Archives of Clinical Psychiatry (São Paulo); Vol. 48 No. 3 (2021); 141-146Revista de Psiquiatria Clínica; Vol. 48 Núm. 3 (2021); 141-1461806-938X0101-6083reponame:Archives of Clinical Psychiatryinstname:Universidade de São Paulo (USP)instacron:USPenghttps://revistas.usp.br/acp/article/view/231766/209968Copyright (c) 2021 Archives of Clinical Psychiatry (São Paulo)info:eu-repo/semantics/openAccessTakizawa , PatcharapimSareedenchai , PairojWongsiri, KanjanaAmornmahaphun, SucheeraKuroda, NaoakiHori , AiIchikawa , Masao2025-02-12T15:03:17Zoai:revistas.usp.br:article/231766Revistahttp://www.hcnet.usp.br/ipq/revista/index.htmlPUBhttps://old.scielo.br/oai/scielo-oai.php||archives@usp.br1806-938X0101-6083opendoar:2025-02-12T15:03:17Archives of Clinical Psychiatry - Universidade de São Paulo (USP)false
dc.title.none.fl_str_mv Impact of duration of untreated psychosis on remission in first-episode schizophrenia in Thailand: a cohort study
title Impact of duration of untreated psychosis on remission in first-episode schizophrenia in Thailand: a cohort study
spellingShingle Impact of duration of untreated psychosis on remission in first-episode schizophrenia in Thailand: a cohort study
Takizawa , Patcharapim
Duration of untreated psychosis
First-episode schizophrenia
Remission
Cohort
Thailand
title_short Impact of duration of untreated psychosis on remission in first-episode schizophrenia in Thailand: a cohort study
title_full Impact of duration of untreated psychosis on remission in first-episode schizophrenia in Thailand: a cohort study
title_fullStr Impact of duration of untreated psychosis on remission in first-episode schizophrenia in Thailand: a cohort study
title_full_unstemmed Impact of duration of untreated psychosis on remission in first-episode schizophrenia in Thailand: a cohort study
title_sort Impact of duration of untreated psychosis on remission in first-episode schizophrenia in Thailand: a cohort study
author Takizawa , Patcharapim
author_facet Takizawa , Patcharapim
Sareedenchai , Pairoj
Wongsiri, Kanjana
Amornmahaphun, Sucheera
Kuroda, Naoaki
Hori , Ai
Ichikawa , Masao
author_role author
author2 Sareedenchai , Pairoj
Wongsiri, Kanjana
Amornmahaphun, Sucheera
Kuroda, Naoaki
Hori , Ai
Ichikawa , Masao
author2_role author
author
author
author
author
author
dc.contributor.author.fl_str_mv Takizawa , Patcharapim
Sareedenchai , Pairoj
Wongsiri, Kanjana
Amornmahaphun, Sucheera
Kuroda, Naoaki
Hori , Ai
Ichikawa , Masao
dc.subject.por.fl_str_mv Duration of untreated psychosis
First-episode schizophrenia
Remission
Cohort
Thailand
topic Duration of untreated psychosis
First-episode schizophrenia
Remission
Cohort
Thailand
description Background: To scale up the services for first-episode schizophrenia in Thailand, it is essential to understand to what extent health care-seeking is delayed, and how much the delay affects the treatment outcome.Objectives: To investigate the duration of untreated psychosis (DUP) and its impact on remission in first-episode schizophrenia across the country.Methods: 276 outpatients with a first-episode schizophrenia were followed for 6 months and assessed whether they fulfilled the criteria for remission at the follow-up. The proportion of those achieving remission was compared by the DUP. The impact of DUP on remission was estimated in multivariate analyses.Results: At the follow-up, 83% (71/86) of patients who had met the criteria for symptomatic remission at the baseline achieved enduring remission, whereas 63% (119/190) of patients who had not met the criteria for symptomatic remission at baseline met it at the follow-up. The shorter the DUP, the higher the proportion of those who achieved symptomatic or enduring remission at the follow-up. The impact of DUP on symptomatic remission appeared to be significant after controlling for other factors influencing remission.Conclusion: Since the DUP would influence remission of patients with schizophrenia, early detection and intervention services should be provided in Thailand
publishDate 2021
dc.date.none.fl_str_mv 2021-06-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://revistas.usp.br/acp/article/view/231766
10.15761/0101-60830000000296
url https://revistas.usp.br/acp/article/view/231766
identifier_str_mv 10.15761/0101-60830000000296
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv https://revistas.usp.br/acp/article/view/231766/209968
dc.rights.driver.fl_str_mv Copyright (c) 2021 Archives of Clinical Psychiatry (São Paulo)
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Copyright (c) 2021 Archives of Clinical Psychiatry (São Paulo)
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Universidade de São Paulo. Faculdade de Medicina. Instituto de Psiquiatria
publisher.none.fl_str_mv Universidade de São Paulo. Faculdade de Medicina. Instituto de Psiquiatria
dc.source.none.fl_str_mv Archives of Clinical Psychiatry; v. 48 n. 3 (2021); 141-146
Archives of Clinical Psychiatry (São Paulo); Vol. 48 No. 3 (2021); 141-146
Revista de Psiquiatria Clínica; Vol. 48 Núm. 3 (2021); 141-146
1806-938X
0101-6083
reponame:Archives of Clinical Psychiatry
instname:Universidade de São Paulo (USP)
instacron:USP
instname_str Universidade de São Paulo (USP)
instacron_str USP
institution USP
reponame_str Archives of Clinical Psychiatry
collection Archives of Clinical Psychiatry
repository.name.fl_str_mv Archives of Clinical Psychiatry - Universidade de São Paulo (USP)
repository.mail.fl_str_mv ||archives@usp.br
_version_ 1848411381046444032